This virtual and in-person symposium is presented by AIM at Melanoma and Roswell Park Comprehensive Cancer Center.
Founded in 1898 and operating from a 29-acre campus on the Buffalo Niagara Medical Campus (BNMC) near downtown Buffalo, New York, Roswell Park today remains the only comprehensive cancer center designated by the National Cancer Institute (NCI) in Upstate New York, and one of only four NCI-designated comprehensive cancer centers in all of New York. In the past year, Roswell Park teams cared for more than 46,000 patients. Roswell Park helps set international standards in cancer care through its role as a founding member of the National Comprehensive Cancer Network, and consistently earns patient-satisfaction scores that are among the highest in the country.
Date: Saturday, April 20, 2024
Time: 8:45 ET| 7:45 CT| 6:45 MT| 5:45 PT
Format: Presented both virtually and in-person
Presenters & Topics
Ben Switzer, DO, MHSA, MS
Assistant Professor of Oncology, Department of Medicine
Gyorgy Paragh, MD, PhD
Associate Professor of Oncology
Chair, Department of Dermatology
Aleodor Andea, MD
Professor of Oncology
Chief, Dermatopathology, Department of Pathology
Mary Reid, MSPH, PhD
Professor of Oncology
Chief, Cancer Screening and Survivorship
Joseph Skitzki, MD, FACS
Associate Professor of Surgery and Immunology
Chair, Melanoma/Sarcoma Disease Site Research Group
Igor Puzanov, MD, MSCI, FACP
Professor of Oncology
Judith and Sanford Lipsey Chair in Clinical Cancer Research
Senior Vice President, Clinical Investigation
Director, Center for Early Phase Clinical Trials
Chief, Division of Melanoma, Department of Medicine
Alicia Larson, MA
Senior Resource Center Coordinator